CUBT logo for press releases.jpg
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
March 22, 2024 09:45 ET | Curative Biotechnology, Inc. 
Palm Beach Gardens, FL, March 22, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel...
CUBT logo for press releases.jpg
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
January 08, 2024 09:45 ET | Curative Biotechnology, Inc. 
Appointment of Independent Director Nominee to become effective upon approval by and listing of common stock on a National Exchange Boca Raton, FL, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Curative...
1672867636549blob.jpg
Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions
June 06, 2023 09:50 ET | Curative Biotechnology, Inc. 
Appoints Paul Michaels Co-CEO of Parent and CEO of Subsidiary Boca Raton, FL, June 06, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a...
1672867636549blob.jpg
Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation
May 24, 2023 10:12 ET | Curative Biotechnology, Inc. 
Topical Administration Capable of Delivering Metformin to Choroid, RPE, and Retina Boca Raton, FL, May 24, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or...
1672867636549blob.jpg
Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study
January 05, 2023 07:50 ET | Curative Biotechnology, Inc. 
Boca Raton, FL, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments...
Logo.jpg
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange
September 27, 2022 07:00 ET | Curative Biotechnology, Inc. 
Boca Raton, FL, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments...
Logo.jpg
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors
June 16, 2022 09:50 ET | Curative Biotechnology, Inc. 
Appointment of Independent Director Builds Upon Biotech Expertise Boca Raton, FL, June 16, 2022 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a...
Logo.jpg
Curative Biotechnology, Inc. Appoints Cary Sucoff to Board of Directors
May 12, 2022 09:30 ET | Curative Biotechnology, Inc. 
Appointment of Independent Director Adds to Financial Expertise on Board Boca Raton, FL, May 12, 2022 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the...
Logo.jpg
Curative Biotechnology Announces Good Laboratory Practice (GLP) Toxicology Studies with Metformin Eye Drop Formulations for Treatment of Macular Degeneration
May 03, 2022 09:30 ET | Curative Biotechnology, Inc. 
National Eye Institute (NEI) to Collaborate with Curative Biotechnology under Cooperative Research and Development Agreement (CRADA) Boca Raton, FL, May 03, 2022 (GLOBE NEWSWIRE) -- Curative...
Logo.jpg
Curative Biotechnology Announces Cooperative Research and Development Agreement (CRADA) with the National Eye Institute (NEI) for Clinical Evaluation of its Proprietary Ocular Metformin Formulation in Age-Related Macular Degeneration
March 21, 2022 09:50 ET | Curative Biotechnology, Inc. 
Emily Y. Chew, M.D. of the National Eye Institute Assigned Principal Investigator Boca Raton, FL, March 21, 2022 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) (“Curative” or the...